Amgen May Join Gilead as Biotechs Seek Acquisitions to Grow

Amgen Inc. and Celgene Corp. may dive into deal-making this year as the biggest biotechnology companies seek to return to the industry’s high-growth roots.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.